Aurash Naser-Tavakolian

Nov 4, 2024 | rand.org | Brennan M. R |Aurash Naser-Tavakolian |Rebecca Gale |Michael Luu

BackgroundPhysician treatment preference may influence how risks are communicated in prostate cancer consultations. We identified persuasive language used when describing cancer prognosis, life expectancy, and side effects in relation to a physician's recommendation for aggressive (surgery/radiation) or nonaggressive (active surveillance/watchful waiting) treatment.

Feb 22, 2024 | nature.com | Timothy J. Daskivich |Aurash Naser-Tavakolian |Nadine A. Friedrich |Howard M. Sandler

AbstractEffective communication of treatment side effects (SE) is critical for shared decision-making (SDM) in localized prostate cancer. We sought to qualitatively characterize how physicians communicate SE in consultations. We transcribed 50 initial prostate cancer treatment consultations across nine multidisciplinary providers (Urologists, Radiation Oncologists, Medical Oncologists) at our tertiary referral, academic center.